Shares of Oracle Corporation (NYSE:ORCL – Get Free Report) fell 5.1% during trading on Monday. The company traded as low as $118.25 and last traded at $118.9370. Approximately 19,985,820 shares were traded during mid-day trading, a decline of 35% from the average daily volume of 30,590,713 shares. The stock had previously closed at $125.35.
Oracle News Summary
These are some of the ORCL news items that stood out recently:
- Positive Sentiment: Shore Medical Center and Shore Physicians Group selected Oracle Health’s AI-powered electronic health record system, expanding Oracle’s healthcare business and extending an existing customer relationship. Article
- Negative Sentiment: Oracle’s planned $90–$95 billion AI data-center buildout, rising debt and negative free cash flow are fueling worries about financing costs, margins and the return on its investment. Article
- Negative Sentiment: Oracle ETFs recorded about $747.8 million in net selling on Nov. 12, adding to evidence of investor caution. Article
Wall Street Analyst Weigh In
ORCL has been the subject of a number of recent research reports. Oppenheimer restated an “outperform” rating and issued a $275.00 target price on shares of Oracle in a research note on Thursday, October 29th. Argus reissued a “buy” rating and issued a $225.00 price target on shares of Oracle in a report on Monday, September 14th. BTIG Research began coverage on shares of Oracle in a research note on Monday, November 2nd. They issued a “buy” rating for the company. Royal Bank Of Canada reduced their price objective on shares of Oracle from $190.00 to $165.00 and set a “sector perform” rating for the company in a report on Friday, September 11th. Finally, UBS Group lifted their target price on shares of Oracle from $245.00 to $250.00 and gave the company a “buy” rating in a research report on Friday, September 11th. One analyst has rated the stock with a Strong Buy rating, thirty-seven have given a Buy rating, five have given a Hold rating and three have assigned a Sell rating to the company’s stock. According to data from MarketBeat, Oracle has an average rating of “Moderate Buy” and an average target price of $249.27.
Check Out Our Latest Report on ORCL
Oracle Stock Down 5.1%
The company has a current ratio of 1.17, a quick ratio of 1.17 and a debt-to-equity ratio of 1.89. The firm’s fifty day moving average price is $136.65 and its 200-day moving average price is $154.07. The company has a market cap of $359.63 billion, a price-to-earnings ratio of 18.64, a price-to-earnings-growth ratio of 0.88 and a beta of 1.79.
Oracle (NYSE:ORCL – Get Free Report) last released its earnings results on Thursday, September 10th. The enterprise software provider reported $1.92 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.74 by $0.18. Oracle had a return on equity of 48.85% and a net margin of 26.36%. The firm had revenue of $19.34 billion during the quarter, compared to analysts’ expectations of $19.13 billion. During the same quarter in the prior year, the company earned $1.47 EPS. The company’s revenue was up 29.6% on a year-over-year basis. Oracle has set its Q2 2027 guidance at 1.850-1.930 EPS and its FY 2027 guidance at 8.100-8.100 EPS. Sell-side analysts predict that Oracle Corporation will post 6.71 earnings per share for the current year.
Oracle Dividend Announcement
The firm also recently disclosed a quarterly dividend, which was paid on Friday, October 23rd. Investors of record on Friday, October 9th were issued a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a yield of 1.7%. The ex-dividend date was Friday, October 9th. Oracle’s dividend payout ratio (DPR) is 31.35%.
Insider Activity
In other Oracle news, Director Stephen H. Rusckowski bought 25,000 shares of the firm’s stock in a transaction that occurred on Tuesday, September 29th. The stock was acquired at an average price of $139.35 per share, with a total value of $3,483,750.00. Following the completion of the purchase, the director directly owned 25,390 shares of the company’s stock, valued at approximately $3,538,096.50. This trade represents a 6,410.26% increase in their position. The purchase was disclosed in a legal filing with the SEC, which is available at this link. Also, EVP Maria Smith sold 2,631 shares of the firm’s stock in a transaction that occurred on Tuesday, September 22nd. The stock was sold at an average price of $151.70, for a total transaction of $399,122.70. Following the sale, the executive vice president directly owned 64,357 shares of the company’s stock, valued at approximately $9,762,956.90. This trade represents a 3.93% decrease in their position. The SEC filing for this sale provides additional information. Over the last 90 days, insiders sold 36,075 shares of company stock valued at $5,342,123. Insiders own 38.40% of the company’s stock.
Institutional Trading of Oracle
A number of hedge funds and other institutional investors have recently bought and sold shares of ORCL. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its holdings in shares of Oracle by 0.8% during the second quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 14,680,278 shares of the enterprise software provider’s stock valued at $2,151,395,000 after purchasing an additional 123,294 shares during the last quarter. Fisher Asset Management LLC grew its stake in shares of Oracle by 3.1% in the third quarter. Fisher Asset Management LLC now owns 13,670,982 shares of the enterprise software provider’s stock worth $1,877,026,000 after acquiring an additional 409,531 shares during the period. Bank of New York Mellon Corp purchased a new stake in Oracle during the 2nd quarter valued at $1,911,930,000. First Eagle Investment Management LLC lifted its holdings in shares of Oracle by 17.8% during the 3rd quarter. First Eagle Investment Management LLC now owns 10,029,416 shares of the enterprise software provider’s stock valued at $1,377,039,000 after buying an additional 1,512,538 shares during the period. Finally, Amundi boosted its stake in shares of Oracle by 1.5% in the 2nd quarter. Amundi now owns 9,878,184 shares of the enterprise software provider’s stock worth $1,447,648,000 after buying an additional 144,087 shares during the last quarter. Institutional investors own 42.44% of the company’s stock.
Oracle Company Profile
Oracle Corporation is a technology company that develops and provides database software, cloud services, and enterprise applications. Its products help organizations manage data, run business operations, and build and deploy applications. Oracle’s offerings include Oracle Database, Oracle Cloud Infrastructure, and cloud-based applications for functions such as finance, human resources, supply chain management, and customer experience. The company also provides software support, consulting, and related services.
Read More
- Five stocks we like better than Oracle
- Ondas Is Building a Defense Growth Engine, But Can It Deliver on Its Backlog?
- Orbiting Growth: Federal Contracts Boost Viasat’s Outlook
- Modine Manufacturing Scales Up to Solve the AI Heat Problem
- Nebius Revenue Is Surging, But Its Spending Is Raising Bigger Questions
Receive News & Ratings for Oracle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oracle and related companies with MarketBeat.com's FREE daily email newsletter.
